Search results
Jul 6, 2023 · 07/06/2023 July 6, 2023. Every vaccination, including the COVID-19 shot, can cause side effects like fatigue and muscle pain. But it is difficult to diagnose so-called post-vaccination syndrome.
- 5 min
- Julia Vergin
Jul 13, 2021 · July 13, 2021. Johnson & Johnson’s beleaguered Covid-19 vaccine may be associated with a small increased risk of Guillain-Barré syndrome, a rare but potentially serious neurological condition ...
Guillain-Barré syndrome (GBS) is a rare disorder where the body’s immune system damages nerve. The damage to the nerves causes muscle weakness and sometimes paralysis. While its cause is not fully understood, the syndrome often follows infection with a virus or bacteria. Each year in the United States, an estimated 3,000 to 6,000 people ...
May 17, 2023 · Guillain-Barré syndrome (GBS) is a rare neurological disorder in which the immune system attacks the nerves. It can cause muscle weakness and sometimes paralysis. People usually recover from it, but it can lead to hospitalization and, sometimes, permanent damage to nerve cells. So, it’s not surprising that people have questions upon hearing ...
- 065208055
- kathy.katella-cofrancesco@yale.edu
Dr. Levin reiterates that the risk of developing Guillain-Barré syndrome after receiving the Johnson & Johnson vaccine is very small, while unvaccinated people’s risk of contracting COVID-19 ...
Aug 30, 2021 · 2. CASE PRESENTATION. A 61‐year‐old gentleman presented to the emergency department with a 3‐day history of bilateral upper limb weakness, more distally, involving the hands and described as an inability to perform fine hand movements such as buttoning his shirt and holding the pen properly when writing.
Dec 17, 2021 · As of Aug 15, 2021, according to the adverse event reports after COVID-19 immunisation in South Korea, acute paralysis events (including Guillain-Barré syndrome) occurred in 620 (0·0059%) of 10 409 265 recipients after at least one dose of the ChAdOx1 nCoV-19 vaccine and in 382 (0·0055%) of 6 908 787 recipients after at least one dose of the ...
